CIK 0001796280 · Non-accelerated filer
Oric Pharmaceuticals, Inc.
Sign in to watch- Ticker
- ORIC
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 471787157
- Phone
- (650) 388-5600
- Business address
- 240 E. GRAND AVE., 2ND FLOOR, SOUTH SAN FRANCISCO, CA, 94080
- 10-Q Report Quarterly Report
- 8-K Event Results of operations · Unregistered share sale · Regulation FD disclosure
- UPLOAD Other SEC-generated Letter
- DRS Other Draft Registration Statement
- 4 Insider Changes in Ownership
- 3 Insider Initial Statement of Ownership
- 8-K Event Executive or director change
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- SC 13G Stake Amended Statement of Ownership
- SC 13G Stake Amended Statement of Ownership
- SC 13D Stake Beneficial Ownership Report
- SC 13G Stake Amended Statement of Ownership
- 4 Insider Changes in Ownership
- 8-K Event Bylaws or fiscal year change · Regulation FD disclosure
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
Page 19 of 22 · 423 filings